PATIENT INFORMATION LEAFLET ZOXADON TABLETS RANGE

Similar documents
PATIENT INFORMATION LEAFLET TEXAMER

PATIENT INFORMATION LEAFLET DYNARB RANGE

PATIENT INFORMATION LEAFLET AMLOC RANGE

PATIENT INFORMATION LEAFLET FOR TEXA 10 mg TABLETS AND TEXA SYRUP PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM:

PATIENT INFORMATION LEAFLET

PATIENT INFORMATION LEAFLET CARZIN XL

Read this entire leaflet carefully before you start taking DYNA BEZAFIBRATE. If you have further questions, please ask your doctor or your pharmacist.

PATIENT INFORMATION LEAFLET BILOCOR RANGE

PATIENT INFORMATION LEAFLET POLLENTYME S AND TABS

PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM: Read this entire leaflet carefully before you start taking DYNAFLOC.

PATIENT INFORMATION LEAFLET SIMVACOR RANGE

PHARMA DYNAMICS CLOPIDOGREL 75 mg PATIENT INFORMATION LEAFLET

POLLENTYME S and Tabs Pharma Dynamics (Pty) Ltd Version: July 2017 (G1639) Word copy of G1639 PATIENT INFORMATION LEAFLET FOR POLLENTYME S AND TABS

PATIENT INFORMATION LEAFLET PEPLOC RANGE

TREANA 5mg and 10mg Film-coated Tablets

PATIENT INFORMATION LEAFLET DYNAFIL RANGE

IMPORTANT: PLEASE READ

MEDICATION GUIDE. Aripiprazole Tablets (AR-i-PIP-ra-zole)

PACKAGE LEAFLET: INFORMATION FOR THE USER Insomniger 10mg and 20mg Tablets (temazepam)

Flecainide BNM. Please read this leaflet carefully before you start taking Flecainide BNM.

PATIENT INFORMATION LEAFLET SINTAIR RANGE

DOPERGIN (Doe PER gin)

MEDICATION GUIDE. Quetiapine (kwe-tye-a-peen) Tablets USP

PACKAGE LEAFLET: INFORMATION FOR THE USER

Risperidone-GA risperidone

Before you take Rixadone. When you must not take it

PATIENT INFORMATION LEAFLET ZYTOMIL RANGE

PATIENT INFORMATION LEAFLET CARVETREND RANGE

Olanzapine generichealth tablets Olanzapine benzoate

OLANZAPINE-SYNTHON Olanzapine benzoate

MEDICATION GUIDE. The risk of getting a serious skin rash is higher if you:

Package leaflet: Information for the user. Aripiprazole Universal Farma 15 mg tablets. Aripiprazole Universal Farma 10 mg tablets

PATIENT INFORMATION LEAFLET PEARINDA PLUS

PACKAGE LEAFLET: INFORMATION FOR THE USER

APO-Ondansetron Contains the active ingredient, ondansetron (as hydrochloride dihydrate)

PACKAGE LEAFLET: INFORMATION FOR THE USER ANQUIL 0.25mg TABLETS Benperidol

Aripiprazole Accord 5, 10, 15 and 30 mg film-coated tablets

PACKAGE LEAFLET: INFORMATION FOR USER ROPINIROLE 2 mg FILM-COATED TABLETS. Ropinirole

Package leaflet: Information for the user. Zolpidem Vitabalans 10 mg film-coated tablets zolpidem tartrate

INVEGA. What is in this leaflet. What Invega is used for. prolonged release tablets. Paliperidone. Consumer Medicine Information (CMI)

Consumer Medicine Information

How Entecavir GH Works

PATIENT INFORMATION LEAFLET FOR FEDALOC 30 mg / 60 mg SR TABLETS. Please read this leaflet carefully before you start taking FEDALOC tablets.

SANDOMIGRAN. 0.5mg tablet Pizotifen malate

LATUDA Lurasidone Hydrochloride

YOUR GUIDE TO ARIPIPRAZOLE Patient/Caregiver Information Brochure

MEDICATION GUIDE TOPIRAMATE

HERNOVIR 200 mg tablets

PATIENT INFORMATION LEAFLET BILOCOR CO RANGE

1. WHAT OXCARBAZEPINE IS AND WHAT IT IS USED FOR

TETRAZIN (tetrabenazine) Tablets MEDICATION GUIDE. What is the most important information I should know about TETRAZIN?

MIRAPEXIN 0.088mg tablets; 0.18mg tablets; 0.35mg tablets; 0.7mg tablets; 1.1mg tablets

PATIENT INFORMATION LEAFLET

Consumer Medicine Information

PACKAGE LEAFLET: INFORMATION FOR THE USER. Dantrium 25 mg Capsules / Dantrium 100 mg Capsules Dantrolene sodium

MEDICATION GUIDE Quetiapine Fumarate Extended-Release Tablets (Kwe-TYE-a-peen FUE-ma-rate)

Otezla (apremilast) film coated tablets

PATIENT INFORMATION LEAFLET: Lancap 15 mg and 30 mg. Please read this leaflet carefully before taking LANCAP capsules.

Sibelium 5 mg Tablets flunarizine

Patient Information VERSACLOZ (VER sa kloz) (clozapine) Oral Suspension

Package leaflet: Information for the patient. Histaclar 10 mg Film-coated Tablets loratadine

ZOLPIDEM PHARMACOR Zolpidem tartrate

CONSUMER MEDICINE INFORMATION

Sandoz Aripiprazole Page 56 of 60

Patient/Caregiver Information Brochure For Bipolar I Disorder in Adolescents

PACKAGE LEAFLET. Page 1 of 8

TRAMAL SR Sustained Release Tablets

Before you take Quetiapine Sandoz. When you must not take it

Chemmart Baclofen Tablets Contains the active ingredient baclofen

EGLONYL FORTE 200mg tablets

Package Leaflet: Information for the User Zofran tablets 4 mg and 8 mg ondansetron (as hydrochloride dihydrate)

Risperidone Sandoz WHAT IS IN THIS LEAFLET BEFORE YOU TAKE RISPERIDONE SANDOZ WHAT RISPERIDONE SANDOZ IS USED FOR. risperidone tablets

Package leaflet: Information for the user

Zeldox (zell-docks) What is in this leaflet. What Zeldox is used for. ziprasidone hydrochloride (zi-pra-si-don hi-dro-klor-ride)

PART III: CONSUMER INFORMATION SAPHRIS (asenapine sublingual tablets)

Consumer Medicine Information

It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist.

PRODUCT MONOGRAPH. Pr KYTRIL. granisetron hydrochloride tablets. 1 mg granisetron as hydrochloride. Manufacture Standard

DIVALPROEX (di val pro ex) SODIUM DELAYED-RELEASE TABLETS, USP

PACKAGE LEAFLET. Page 1 of 6

RISPERIDONE GENERICHEALTH

The name of your medicine is Depixol 3 mg film-coated tablets (called Depixol Tablets in this leaflet).

PART III: CONSUMER INFORMATION SAPHRIS (asenapine sublingual tablets)

PART III: CONSUMER INFORMATION. topiramate tablets

Onglyza CONSUMER MEDICINE INFORMATION

MEDICATION GUIDE LAMOTRIGINE TABLETS

PACKAGE LEAFLET: INFORMATION FOR THE USER ZIRPINE 10mg TABLETS Cetirizine dihydrochloride

MEDICATION GUIDE LEVETIRACETAM (LEE-ve-tye-RA-se-tam) TABLETS USP 250 mg, 500 mg, 750 mg and 1000 mg Rx only

Zofran tablets contain a medicine called ondansetron. This belongs to a group of medicines called anti-emetics.

Package leaflet: Information for the user

Kventiax 25mg and 100mg Film-coated Tablets

Package leaflet: Information for the user

MEDICATION GUIDE Valproic Acid (val pro ic acid) Capsules

Transcription:

SCHEDULING STATUS: S5 PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM: ZOXADON 0,5 mg: Each tablet contains 0,5 mg risperidone. ZOXADON 1 mg: Each tablet contains 1 mg risperidone. ZOXADON 2 mg: Each tablet contains 2 mg risperidone. ZOXADON 3 mg: Each tablet contains 3 mg risperidone. ZOXADON 4 mg: Each tablet contains 4 mg risperidone. Read this entire leaflet carefully before you start taking ZOXADON. Keep this leaflet. You may need to read it again. If you have further questions, please ask your doctor or your pharmacist. This medicine has been prescribed for you personally and you should not share your medicine with other people. It may harm them, even if their symptoms are the same as yours. 1. WHAT ZOXADON CONTAINS: Active ingredient: risperidone. Inactive ingredients: Lactose monohydrate, magnesium stearate, microcrystalline cellulose, Opadry white or yellow, and pregelatinised starch. Contains sugar in the form of lactose monohydrate (See BEFORE YOU TAKE ZOXADON). 2. WHAT ZOXADON IS USED FOR: Risperidone is an atypical antipsychotic. ZOXADON is indicated for: Acute and chronic schizophrenia and related psychosis in which positive symptoms and/or the negative symptoms are prominent. Page 1 of 7

Behavioural disturbances in patients with dementia in whom symptoms such as aggressiveness, activity disturbances or psychotic symptoms are prominent. Conduct and other disruptive behaviour disorders in children (aged 5-12 years), with subaverage intellectual functioning or mental retardation in whom destructive behaviours are prominent. 3. BEFORE YOU TAKE ZOXADON: Do not take ZOXADON: If you are hypersensitive (allergic) to risperidone, or to any of the other ingredients of ZOXADON. If you are pregnant or breastfeeding your baby. Do not give this medicine to children under 5 years with conduct and other disruptive behaviour disorders. Take special care with ZOXADON: Tell your doctor: If you suffer from kidney or liver function impairment. If you suffer from Parkinson's disease: muscle weakness, muscle stiffness, impaired and slow movement and shaking. ZOXADON may worsen the symptoms of these conditions. If you suffer from epilepsy: fits I seizures. ZOXADON may worsen the symptoms of this condition. If you have a condition called tardive dyskinesia: characterised by jaw movements, chewing-like movements, tongue movements, smacking of the lips or involuntary rapid arm or leg movements. If you experience any of the following symptoms of neuroleptic malignant syndrome: muscle spasms, irregular pulse or blood pressure, high fever, irregular heart rate, Page 2 of 7

increased heart rate and increased sweating (perspiration). If you take furosemide water tablets. If you have diabetes: high blood sugar. If you have a history of cerebrovascular adverse events: strokes. If you suffer from heart disease or have low blood pressure. If you have a history of galactose intolerance (a simple sugar found in lactose) or impaired absorption of glucose-galactose. If you are old aged or suffer from dementia (progressive intellectual impairment) associated with Parkinsonism. If you are planning to have an eye operation, intraoperative floppy iris syndrome may increase the risk of eye complications during and after cataract surgery. If you have a tendency to over-eat or gain weight easily. Pregnancy and breastfeeding: The safety of ZOXADON in pregnant and breast-feeding women has not yet been established. If you are pregnant or breast feeding your baby, please consult your doctor, pharmacist or other health care professional for advice before taking this medicine. Driving and using machines: ZOXADON may cause sleepiness and a lack of concentration. Do not drive or operate any machinery before you know how this medicine affects you. Using other medicines with ZOXADON: Always tell your healthcare professional if you are taking any other medicine. (This includes complementary or traditional medicines.) Do not take alcohol and ZOXADON simultaneously. Consult your doctor or pharmacist before taking other centrally acting medicines (e.g. Page 3 of 7

sleeping tablets). ZOXADON may cause levodopa and other dopamine agonists (used to treat Parkinson's disease) to be less effective. Chronic administration of carbamazepine and clozapine may decrease the plasma levels of ZOXADON. Fluoxetine and paroxetine (an antidepressant medicine) may increase the plasma concentration of ZOXADON. Tell your doctor if you are using any medication that will cause your blood pressure to fall. Concomitant use of such medication and ZOXADON may, cause very low blood pressure. 4. HOW TO TAKE ZOXADON: Always take ZOXADON exactly as your doctor has instructed you. You should check with your doctor or pharmacist if you are unsure. If you have the impression that the effect of ZOXADON is too strong or too weak, talk to your doctor or pharmacist. Treatment of schizophrenia: If you are already using an antipsychotic medicine, your doctor may gradually discontinue this treatment when switching to ZOXADON. If you are receiving a depot injection, your doctor will initiate ZOXADON treatment in place of the next scheduled injection. You may take ZOXADON either once daily or twice daily. Initial adult dose: The usual dose is 2 mg per day. Your doctor may increase the dosage to 4 mg per day on the second day. Maintenance dose: Your doctor will decide what the optimum maintenance dose is based on your response. The usual maintenance dose is 4 mg to 8 mg daily, but your doctor may increase the total dose up to 16 mg per day. Liver and kidney impairment: Your doctor should halve both the starting dose and the subsequent dose increments if you Page 4 of 7

suffer for liver or kidney impairment. Elderly patients: The starting dose is usually 0,5 mg twice daily. Your doctor may increase the dose up to 1-2 mg twice daily. Treatment of behavioural disturbances in patients with dementia The usual starting dose is 0,25 mg twice daily. Your doctor may increase the dose to a maintenance dose of 0,5 mg to 1 mg twice daily. Treatment of conduct and other disruptive behaviour disorders in children 5-12 years of age The usual starting dose is 0,01 mg per kg once daily. The doctor may increase the dose to a maintenance dose of 0,02-0,04 mg per kg once daily. If you take more ZOXADON than you should: In the event of overdosage, consult your doctor or pharmacist. If neither is available, contact the nearest hospital or poison control centre. If you forget to take ZOXADON: If you missed a dose, take the missed dose as soon as you remember. If it is almost time for your next dose, skip the missed dose and continue to take the medicine at the usual time. Do not take a double or larger dose to make up the forgotten individual doses. If you have trouble remembering when to use your medicine, ask your pharmacist for some hints. 5. POSSIBLE SIDE EFFECTS: ZOXADON can have side effects. Not all side effects reported for this medicine are included in this leaflet. Should your general health worsen while taking this medicine please consult your doctor, pharmacist or other health care professional for advice. Page 5 of 7

If any of the following happens, stop taking ZOXADON and tell your doctor immediately or go to the casualty department at your nearest hospital: Less frequent occurrence Fast or irregular heart beat Difficult or unusually fast breathing, high fever, irregular blood pressure, toss of bladder control, severe muscle stiffness, seizures, unusual pale skin, tiredness of weakness. Cough difficulty swallowing, dizziness, hives, itching, tightness in chest, wheezing and puffiness or swelling of eyelids, face, lips or tongue. These are all very serious side effects. If you have them, you may have had a serious allergic reaction to ZOXADON. You may need urgent medical attention or hospitalization. Tell your doctor if any of the following side effects occur: Frequent occurrence Restlessness or need to keep moving Anxiety or nervousness Muscle spasm of face, neck and back, twitching movements, weakness of arms or legs Difficulty in speaking or swallowing, loss of balance control, trembling and shaking of hands and fingers Insomnia; asthenia; fatigue; lassitude; drowsiness; headache; increased dream activity; increased duration of sleep Changes in vision Constipation, diarrhoea; dyspepsia; vomiting; nausea Skin rash or itching Problems in urination or increase in amount of urine Page 6 of 7

Mood or mental changes, including aggressive behaviour, agitation, difficulty in concentration and memory problems Sexual dysfunction or decrease libido; menstrual changes Less frequent occurrence Back pain Menstrual changes; unusual secretion of milk; prolonged and painful erection of the penis If you notice any side effects not mentioned in this leaflet, please inform your doctor or pharmacist. 6. STORING AND DISPOSING OF ZOXADON: Store at or below 25 C. For tablets in blisters: Keep the blisters in the carton until required for use. For tablets in containers: Keep well closed in the original container. Do not use the tablets after the expiry date printed on the blister/ container. Return all unused medicine to your pharmacist Do not dispose of unused medicine in drains and sewerage systems (e.g. toilets) STORE ALL MEDICINES OUT OF REACH OF CHILDREN Page 7 of 7